Giovanni Merlino1,2, Mariarosaria Valente1,2, Anna Serafini1, Lara Fratticci1, Angela Del Giudice1, Antonella Piani1, Claudio Noacco3, Gian Luigi Gigli2. 1. The Sleep Disorder Center, Neurology and Clinical Neurophysiology, Santa Maria della Misericordia University Hospital, Udine, Italy (Dr Merlino, Dr Valente, Dr Serafini, Dr Fratticci, Dr Del Guidice, Dr Piani, Dr Gigli) 2. The DPMSC, University of Udine, Italy (Dr Merlino, Dr Valente, Dr Gigli) 3. The Diabetes Center, Santa Maria della Misericordia University Hospital, Udine, Italy (Dr Noacco)
Abstract
PURPOSE: The purpose of this study was to evaluate the effects of restless legs syndrome (RLS) on quality of life (QoL), anxiety, and depression in people with type 2 diabetes. METHODS: One hundred twenty-four patients with type 2 diabetes were enrolled in this study. RLS was diagnosed by a neurologist masked on psychological evaluation. Data on severity, frequency, and duration of the sleep disorder were collected. The Italian version of the SF-36 was used to assess QoL. Psychological status was investigated by a neuropsychologist masked on RLS diagnosis. Patients with a diagnosis of generalized anxiety disorder (GAD) and major depressive disorder (MDD) were considered affected by anxiety and depression, respectively. A modified version of the Hamilton Anxiety and Depression Rating Scales (HARS and HDRS) was also administered. RESULTS: RLS was an independent predictor for several mental domains of the SF-36 and for the mental component summary. Multivariate analysis showed that RLS was an independent predictor of anxiety and depression. RLS severity correlated with HARS and HDRS scores, whereas frequency per week of RLS had a significant correlation only with HARS score. CONCLUSIONS: Among individuals with diabetes, RLS can impair mental health, increasing the risk for anxiety and depression. Since RLS consequences on nocturnal rest and psychological status may impair glycemic control in this population, diabetologists and diabetes educators should investigate for the presence of RLS in their patients and treat them.
PURPOSE: The purpose of this study was to evaluate the effects of restless legs syndrome (RLS) on quality of life (QoL), anxiety, and depression in people with type 2 diabetes. METHODS: One hundred twenty-four patients with type 2 diabetes were enrolled in this study. RLS was diagnosed by a neurologist masked on psychological evaluation. Data on severity, frequency, and duration of the sleep disorder were collected. The Italian version of the SF-36 was used to assess QoL. Psychological status was investigated by a neuropsychologist masked on RLS diagnosis. Patients with a diagnosis of generalized anxiety disorder (GAD) and major depressive disorder (MDD) were considered affected by anxiety and depression, respectively. A modified version of the Hamilton Anxiety and Depression Rating Scales (HARS and HDRS) was also administered. RESULTS: RLS was an independent predictor for several mental domains of the SF-36 and for the mental component summary. Multivariate analysis showed that RLS was an independent predictor of anxiety and depression. RLS severity correlated with HARS and HDRS scores, whereas frequency per week of RLS had a significant correlation only with HARS score. CONCLUSIONS: Among individuals with diabetes, RLS can impair mental health, increasing the risk for anxiety and depression. Since RLS consequences on nocturnal rest and psychological status may impair glycemic control in this population, diabetologists and diabetes educators should investigate for the presence of RLS in their patients and treat them.
Authors: Thiago Medeiros da Costa Daniele; Veralice Meireles Sales de Bruin; Adriana Costa e Forte; Débora Siqueira Nobre de Oliveira; Clara Mota Randal Pompeu; Pedro Felipe Carvalhedo de Bruin Journal: Endocrine Date: 2012-12-01 Impact factor: 3.633
Authors: Christoforos D Giannaki; Giorgos K Sakkas; Christina Karatzaferi; Georgios M Hadjigeorgiou; Eleftherios Lavdas; Vassilios Liakopoulos; Nikolaos Tsianas; Georgios N Koukoulis; Yiannis Koutedakis; Ioannis Stefanidis Journal: PLoS One Date: 2011-10-03 Impact factor: 3.240
Authors: Samantha B J Schipper; Maaike M Van Veen; Petra J M Elders; Annemieke van Straten; Ysbrand D Van Der Werf; Kristen L Knutson; Femke Rutters Journal: Diabetologia Date: 2021-08-16 Impact factor: 10.122
Authors: Abhinav Khanna; Amber L Bush; J Michael Swint; Melissa Fleschler Peskin; Richard L Street; Aanand D Naik Journal: Health Qual Life Outcomes Date: 2012-05-14 Impact factor: 3.186